🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "specific action to deal with cost of living pressures" in the forthcoming financial statement.

In comments to media outlets, she emphasized that lowering inflation is a shared responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the G7 developed nations this calendar year and the following year.

Possible Energy Bill Interventions

It is understood the administration could take action to bring down utility costs, for instance by slashing the present 5% level of value-added tax charged on energy.

Another approach is to cut some of the government charges currently added to household expenses.

Fiscal Limitations and Analyst Predictions

The government will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for these actions.

The view from most economists is that Reeves will have to announce tax increases or expenditure reductions in order to adhere to her voluntary borrowing rules.

Previously on Thursday, analysis showed there was a £22 billion shortfall for the chancellor to address, which is at the lower end of forecasts.

"It is a collective job between the Bank of England and the government to further reduce some of the causes of price increases," Reeves told reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Pledges and Global Concerns

While much of the focus has been on likely tax increases, the Treasury chief said the latest information from the OBR had not changed her pledge to election pledges not to raise rates on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with rising international and trade tensions for the fiscal tax moves, likely to be targeted on those "wealthiest."

Global Trade Disputes

Commenting on worries about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security always take priority."

Last week's announcement by Chinese authorities to strengthen trade restrictions on critical minerals and other materials that are essential for advanced tech production led American leader the US President to suggest an additional 100% tariff on imports from China, increasing the possibility of an full-scale commercial conflict between the two largest economies.

The American finance chief labeled China's decision "economic coercion" and "a global supply chain power grab."

Asked about accepting the US offer to participate in its battle with China, the Chancellor said she was "deeply worried" by Chinese actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "bad for the global economy and generates additional obstacles."

"I believe there are areas where we need to address China, but there are also significant prospects to sell into China's economy, including financial services and other sectors of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also stated she was collaborating with international partners "on our own critical minerals plan, so that we are less reliant."

NHS Medicine Costs and Funding

The Chancellor also admitted that the price the NHS spends on pharmaceuticals could increase as a result of current discussions with the US government and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said lately that they are either pausing or canceling operations in the UK, with several blaming the low prices they are obtaining.

Recently, the Science Minister said the cost the NHS pays for drugs would must go up to stop companies and drug research funding leaving the UK.

The Chancellor informed media: "It has been observed due to the pricing regime, that clinical trials, recent pharmaceuticals have not been provided in the UK in the manner that they are in other European countries."

"Our aim is to ensure that individuals getting treatment from the National Health Service are able to receive the finest critical medicines in the globe. And so we are examining these issues, and... seeking to obtain increased funding into Britain."